These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23843989)

  • 21. Detrimental effect of renin-angiotensin blockade on progression of chronic kidney disease at later stages: A matter of dosage adjustment?
    Caravaca-Fontán F; Valladares J; Díaz-Campillejo R; Barroso S; Luna E; Caravaca F
    Nefrologia (Engl Ed); 2020; 40(1):38-45. PubMed ID: 31196659
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimated glomerular filtration rate variability and risk of end-stage renal disease among patients with Stage 3 chronic kidney disease.
    Perkins RM; Kirchner HL; Hartle JE; Bucaloiu ID
    Clin Nephrol; 2013 Oct; 80(4):256-62. PubMed ID: 23993165
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations Between Weight Loss, Kidney Function Decline, and Risk of ESRD in the Chronic Kidney Disease in Children (CKiD) Cohort Study.
    Ku E; Kopple JD; McCulloch CE; Warady BA; Furth SL; Mak RH; Grimes BA; Mitsnefes M
    Am J Kidney Dis; 2018 May; 71(5):648-656. PubMed ID: 29132947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis.
    Kovesdy CP; Matsushita K; Sang Y; Brunskill NJ; Carrero JJ; Chodick G; Hasegawa T; Heerspink HL; Hirayama A; Landman GWD; Levin A; Nitsch D; Wheeler DC; Coresh J; Hallan SI; Shalev V; Grams ME;
    Eur Heart J; 2018 May; 39(17):1535-1542. PubMed ID: 29554312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of dyskalemias with short-term health care utilization in patients with advanced CKD.
    Dashputre AA; Gatwood J; Sumida K; Thomas F; Akbilgic O; Potukuchi PK; Obi Y; Molnar MZ; Streja E; Kalantar-Zadeh K; Kovesdy CP
    J Manag Care Spec Pharm; 2021 Oct; 27(10):1403-1415. PubMed ID: 34595956
    [No Abstract]   [Full Text] [Related]  

  • 26. Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease.
    Garlo KG; Bates DW; Seger DL; Fiskio JM; Charytan DM
    JAMA Netw Open; 2018 Nov; 1(7):e183874. PubMed ID: 30646338
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The prevalence, influencing factors and prognosis of abnormal serum potassium levels in patients with chronic kidney disease].
    Wang F; Yang C; Gao BX; Zhang LX; Zhao MH; Wang JW
    Zhonghua Yi Xue Za Zhi; 2021 Nov; 101(42):3459-3465. PubMed ID: 34775702
    [No Abstract]   [Full Text] [Related]  

  • 28. Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A report from the Chronic Renal Insufficiency Cohort (CRIC) study.
    Dobre M; Yang W; Pan Q; Appel L; Bellovich K; Chen J; Feldman H; Fischer MJ; Ham LL; Hostetter T; Jaar BG; Kallem RR; Rosas SE; Scialla JJ; Wolf M; Rahman M;
    J Am Heart Assoc; 2015 Apr; 4(4):. PubMed ID: 25896890
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Relation of Serum Potassium Concentration with Cardiovascular Events and Mortality in Community-Living Individuals.
    Hughes-Austin JM; Rifkin DE; Beben T; Katz R; Sarnak MJ; Deo R; Hoofnagle AN; Homma S; Siscovick DS; Sotoodehnia N; Psaty BM; de Boer IH; Kestenbaum B; Shlipak MG; Ix JH
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):245-252. PubMed ID: 28143865
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study.
    Lee JY; Park JT; Joo YS; Lee C; Yun HR; Yoo TH; Kang SW; Choi KH; Ahn C; Oh KH; Sung S; Kim SW; Lee J; Han SH;
    Am J Kidney Dis; 2021 Aug; 78(2):236-245. PubMed ID: 33444666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum Potassium and Cardiovascular Events in Heart Failure With Preserved Left Ventricular Ejection Fraction Patients.
    Nishihara T; Tokitsu T; Sueta D; Takae M; Oike F; Fujisue K; Usuku H; Takashio S; Hanatani S; Kanazawa H; Arima Y; Sakamoto K; Izumiya Y; Yamabe H; Kaikita K; Yamamoto E; Tsujita K
    Am J Hypertens; 2018 Sep; 31(10):1098-1105. PubMed ID: 29985986
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum Potassium, Mortality, and Kidney Outcomes in the Atherosclerosis Risk in Communities Study.
    Chen Y; Chang AR; McAdams DeMarco MA; Inker LA; Matsushita K; Ballew SH; Coresh J; Grams ME
    Mayo Clin Proc; 2016 Oct; 91(10):1403-1412. PubMed ID: 27499535
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loop and thiazide diuretic use and risk of chronic kidney disease progression: a multicentre observational cohort study.
    Fitzpatrick JK; Yang J; Ambrosy AP; Cabrera C; Stefansson BV; Greasley PJ; Patel J; Tan TC; Go AS
    BMJ Open; 2022 Jan; 12(1):e048755. PubMed ID: 35105612
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum potassium and outcomes in CKD: insights from the RRI-CKD cohort study.
    Korgaonkar S; Tilea A; Gillespie BW; Kiser M; Eisele G; Finkelstein F; Kotanko P; Pitt B; Saran R
    Clin J Am Soc Nephrol; 2010 May; 5(5):762-9. PubMed ID: 20203167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-year estimated glomerular filtration rate variability after pre-end-stage renal disease program enrollment and adverse outcomes of chronic kidney disease.
    Tsai CW; Huang HC; Chiang HY; Chung CW; Chiu HT; Liang CC; Yu T; Kuo CC
    Nephrol Dial Transplant; 2019 Dec; 34(12):2066-2078. PubMed ID: 29982714
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renal Morphology, Clinical Findings, and Progression Rate in Mesoamerican Nephropathy.
    Wijkström J; González-Quiroz M; Hernandez M; Trujillo Z; Hultenby K; Ring A; Söderberg M; Aragón A; Elinder CG; Wernerson A
    Am J Kidney Dis; 2017 May; 69(5):626-636. PubMed ID: 28126239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dyskalemia in Chronic Kidney Disease: How Concerned Should We Be?
    Tandukar S; Fried LF
    Nephron; 2018; 140(1):58-62. PubMed ID: 29972830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Pre-ESRD Serum Bicarbonate with Post-ESRD Mortality in Patients with Incident ESRD.
    Tantisattamo E; Murray V; Obi Y; Park C; Catabay CJ; Lee Y; Wenziger C; Hsiung JT; Soohoo M; Kleine CE; Rhee CM; Kraut J; Kovesdy CP; Kalantar-Zadeh K; Streja E
    Am J Nephrol; 2021; 52(4):304-317. PubMed ID: 33895727
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.